Next Article in Journal
HSF1 Regulates Mevalonate and Cholesterol Biosynthesis Pathways
Next Article in Special Issue
Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice
Previous Article in Journal
In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome
Previous Article in Special Issue
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
 
 
Article

Article Versions Notes

Cancers 2019, 11(9), 1362; https://doi.org/10.3390/cancers11091362
Action Date Notes Link
article xml file uploaded 13 September 2019 10:35 CEST Original file -
article xml uploaded. 13 September 2019 10:35 CEST Update https://www.mdpi.com/2072-6694/11/9/1362/xml
article pdf uploaded. 13 September 2019 10:35 CEST Version of Record https://www.mdpi.com/2072-6694/11/9/1362/pdf
article supplementary file uploaded. 13 September 2019 10:35 CEST - https://www.mdpi.com/2072-6694/11/9/1362#supplementary
article html file updated 13 September 2019 10:37 CEST Original file -
article html file updated 13 September 2019 10:38 CEST Update -
article html file updated 13 September 2019 10:40 CEST Update -
article html file updated 27 September 2019 09:36 CEST Update -
article html file updated 13 February 2020 17:27 CET Update -
article html file updated 20 July 2022 03:27 CEST Update https://www.mdpi.com/2072-6694/11/9/1362/html
Back to TopTop